
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

French venture investor creating and funding life sciences and information technology companies across France and Europe

Truffle Capital is a French business builder that has been creating, financing and developing companies for about twenty-five years, according to its current site. It works in two fields: life sciences, covering MedTech and biotech, and deep technology applied to finance, covering fintech and insurtech. Its mission is to produce companies that can become leaders in biomedtech and in finance and insurance.
The firm describes itself as acting as a founder systematically in biomedtech, as a lead investor in financing rounds, and as proactive in governance. It says it works closely with a set of fifty universities, selecting and transforming their most significant inventions into technology, medical devices and treatments. Its site also says it follows its companies from creation through to monetisation, which it presents as a rare approach among European funds.
Since 2014 the firm has concentrated on fintech, with a dedicated team that selects products and services built on complex, deep technology. It has published research on the sector, including a study on the super app race and crypto. Together with Finance Innovation, it produced the first Fintech100 ranking of French insurtech and fintech companies, and it reports that business-to-business demand remains the main engine of growth for both sectors.
Its site names Carvolix, a company in its portfolio that has attracted financing from outside investors, and Evexta Bio, which has agreed a clinical trial collaboration and supply arrangement with Roche. It also lists PK MED, which is strengthening its scientific governance to develop therapeutic micro-implants, and iPaidThat, a business that handles electronic invoicing for French companies.
The website says that environmental, social and governance issues sit at the centre of Truffle's DNA and investment strategy. The firm presents its leadership as a group of medical, financial and accounting specialists, and it describes its governance as an active part of how it works with the companies it backs.
Truffle Capital is a French venture investment firm that has been operating for about twenty years. It creates and finances young companies in France and elsewhere in Europe, working in two areas: life sciences and information technology.
The firm describes itself as following its companies from their creation through to a sale or listing. It works with universities around the world to pick out research that can become medical devices, drug treatments or other technology products.
Founders and research teams building technology or medical companies, mainly in France and Europe.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Truffle Capital.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Venture capital firm partnering with founders from first idea through to public listing

Global investment platform putting capital into fintech and financial services companies at all stages

A long-established investment firm that invests its own permanent capital across private companies and public securities

Private real estate investor buying and managing single-tenant retail properties across the United States

Venture firm partnering with founders to build lasting technology companies, from seed stage onward

Baden-Württemberg agency promoting the region's health industry, life sciences and bioeconomy
Everything here links back to the same verified catalogue. Pick your next stop.